PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study

NCT00115765 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1053

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Oxaliplatin Based Chemotherapy
DRUG: Panitumumab
DRUG: Irinotecan Based Chemotherapy
DRUG: Bevacizumab

Sponsor

Amgen